Effects of angiotensin-converting enzyme inhibitors and digoxin on health outcomes of very old patients with heart failure. SAGE Study Group. Systematic Assessment of Geriatric drug use via Epidemiology

Giovanni Gambassi, Antonio Sgadari, Roberto Bernabei, Pierugo Carbonin, Kl Lapane, C Gatsonis, La Lipsitz, V Mor

Research output: Contribution to journalArticle

Abstract

Randomized trials have shown that angiotensin-converting enzyme (ACE) inhibitors reduce mortality and morbidity, and improve symptoms and exercise tolerance in selected patients with congestive heart failure (CHF). There is, however, no evidence on the effectiveness of ACE inhibitors in the typical, very old and frail patients with CHF.
Original languageEnglish
Pages (from-to)53-60
Number of pages8
JournalArchives of Internal Medicine
Volume160
Publication statusPublished - 2000

Keywords

  • Activities of Daily Living
  • Aged
  • Aged, 80 and over
  • Angiotensin-Converting Enzyme Inhibitors
  • Cardiotonic Agents
  • Confounding Factors (Epidemiology)
  • Digoxin
  • Drug Therapy, Combination
  • Female
  • Heart Failure
  • Hospitalization
  • Humans
  • Male
  • Proportional Hazards Models
  • Retrospective Studies
  • Risk
  • Treatment Outcome

Fingerprint

Dive into the research topics of 'Effects of angiotensin-converting enzyme inhibitors and digoxin on health outcomes of very old patients with heart failure. SAGE Study Group. Systematic Assessment of Geriatric drug use via Epidemiology'. Together they form a unique fingerprint.

Cite this